CliniCrowd

Company Overview

Snapshot

Founded in August 2016 by Michal Kahan, Ran Cohen, Irit (Friedman) Shefer, and Amir Sadeh, CliniCrowd operates with 1–10 employees. The company ceased operations in November 2021.

Business overview

CliniCrowd leverages crowdsourcing for the rapid and cost-effective testing of nutriments, focusing on those often overlooked by the pharmaceutical industry. The company's platform investigates solutions with therapeutic potential, particularly those that have shown promise in animal models but lack financial incentives for traditional randomized controlled trials. Utilizing artificial intelligence, machine learning, and big data analytics, CliniCrowd collects real-world patient data to generate insights for improving patient well-being, enabling early disease detection, and preventing chronic conditions. It operates within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Pharma & Medical Biotechnology, targeting patients, providers, and pharmaceutical companies.

Strategic signal

In December 2021, Bar-Ilan University researchers chronicled how CliniCrowd's crowdsourcing approach helped turn an orphan drug into a potential treatment for Parkinson's. This highlights the company's innovative model for validating therapeutic potential outside traditional pharmaceutical development pathways, demonstrating the impact of community-driven research in addressing unmet medical needs.

Company Intelligence Q&A

What is CliniCrowd's primary focus?

CliniCrowd focuses on community testing and validation of nutriments, particularly those that are currently ignored by the pharmaceutical industry, to prevent disease progression or its development in at-risk individuals.

When was CliniCrowd founded?

CliniCrowd was founded in August 2016.

What technologies does CliniCrowd utilize in its platform?

CliniCrowd's platform utilizes artificial intelligence, machine learning, and big data analytics to collect and analyze real-world data from patients.

What was a notable achievement for CliniCrowd in late 2021?

In December 2021, researchers from Bar-Ilan University chronicled how CliniCrowd's crowdsourcing methodology contributed to transforming an orphan drug into a potential treatment for Parkinson's disease.

What is the current operational status of CliniCrowd?

CliniCrowd is currently non-active, having ceased operations in November 2021.